The research aims to develop novel mass spectrometry-based bioanalytical chemistry techniques to understand the disease mechanisms, and discover potential therapeutic targets for frontotemporal dementia, the most common form of dementia for people under age 60. This grant will support a number of major research projects in the Hao Lab for the next five years! Congratulations to Dr. Hao and all the Hao Lab members!
Skip to content
Advancing Mass Spectrometry-based bioanalytical techniques to study human diseases
GW is committed to digital accessibility. If you experience a barrier that affects your ability to access content on this page, let us know via the Accessibility Feedback Form.